Electronic informed consent (eIC) has been slow to adopt in clinical research since its advent, despite the many benefits to its use. As COVID-19 has pushed the world to embrace innovation, eIC has quickly become a necessity, especially in light of guidance from the FDA and NIH recognizing the urgent need for more digital health technology in our health system.
In this white paper, readers will learn:
- The benefits of eIC for participants, researchers, and sponsors.
- How to set up your eIC process to be fully compliant.
- Considerations for trials that haven’t launched and for studies currently running.